Evidence map›Paper›PMID 32022559›Full record

ArticleJournal of natural products2020

The Marine Natural Product Manzamine A Inhibits Cervical Cancer by Targeting the SIX1 Protein.

Dev Karan, Seema Dubey, Lucia Pirisi, Alexis Nagel, Ivett Pina, Yeun-Mun Choo, Mark T Hamann

Open access · bronzeAbstract read
In one paragraph

Article in Journal of natural products, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 3 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 3 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Manzamine-A AltersJournal of natural products · 2024
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Dev KaranDepartment of Pathology, MCW Cancer Center and Prostate Cancer Center of Excellence , Medical College of Wisconsin , 8701 Watertown Plank Road , Milwaukee , Wisconsin , United States.ORCID 0000-0002-0905-0886
Seema DubeyDepartment of Pathology, MCW Cancer Center and Prostate Cancer Center of Excellence , Medical College of Wisconsin , 8701 Watertown Plank Road , Milwaukee , Wisconsin , United States.
Lucia PirisiDepartment of Pathology, Microbiology and Immunology , University of South Carolina School of Medicine , Columbia , South Carolina , United States.
Alexis NagelDepartment of Drug Discovery and Biomedical Sciences , Medical University of South Carolina , Charleston , South Carolina , United States.ORCID 0000-0002-3798-4002
Ivett PinaDepartment of Drug Discovery and Biomedical Sciences , Medical University of South Carolina , Charleston , South Carolina , United States.
Yeun-Mun ChooDepartment of Chemistry , University of Malaya , Kuala Lumpur , Malaysia.
Mark T HamannDepartment of Drug Discovery and Biomedical Sciences , Medical University of South Carolina , Charleston , South Carolina , United States.
Medical University of South Carolina · USMedical College of Wisconsin · USUniversity of Malaya · MYUniversity of South Carolina · US

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Jian Ouyang · 2009 to 2026
$42.7M
Natural Product HCV Drugs from Rare Plant-Microbe InteractionsR01AT007318 · NCCIH · UNIVERSITY OF MISSISSIPPI · PI HAMANN, MARK T · 2012 to 2016
$1.6M
Modulation of NK cell activity by dietary product for prostate cancer preventionR21CA169453 · NCI · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI KARAN, DEV · 2012 to 2013
$351k
Racial disparity of MIC-1 gene in prostate tumor biologyR21CA179733 · NCI · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI KARAN, DEV · 2014 to 2015
$319k
NCCIH NIH HHS R01 AT007318NCI NIH HHS P30 CA138313NCI NIH HHS R21 CA169453NCI NIH HHS R21 CA179733
6 · The paper itself

Abstract

Natural products remain an important source of drug leads covering unique chemical space and providing significant therapeutic value for the control of cancer and infectious diseases resistant to current drugs. Here, we determined the antiproliferative activity of a natural product manzamine A (

Indexed as

ApoptosisBiological ProductsCarbazolesCell Line, TumorEcosystemFemaleHeLa CellsHomeodomain ProteinsHumansStructure-Activity RelationshipUterine Cervical NeoplasmsBiological ProductsCarbazolesHomeodomain Proteinsmanzamine ASIX1 protein, human

Identifiers

PMID32022559
PMCPMC7161578
OpenAlexW3004674139

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.